Drug Type CAR-T |
Synonyms |
Target- |
Mechanism Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Verismo Therapeutics, Inc.Startup |
Active Organization Verismo Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | Verismo Therapeutics, Inc.Startup | 14 Mar 2023 |